Related references
Note: Only part of the references are listed.Resistance exercise shifts the balance of renin-angiotensin system toward ACE2/Ang 1-7 axis and reduces inflammation in the kidney of diabetic rats
Ralmony de Alcantara Santos et al.
LIFE SCIENCES (2021)
Both Specific Endothelial and Proximal Tubular Adam17 Deletion Protect against Diabetic Nephropathy
Vanesa Palau et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Gut microbiota dysbiosis-induced activation of the intrarenal renin-angiotensin system is involved in kidney injuries in rat diabetic nephropathy
Chen-chen Lu et al.
ACTA PHARMACOLOGICA SINICA (2020)
Diabetes-induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation
Yang Yanhui et al.
FASEB JOURNAL (2020)
Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis
Xiu-wu Pan et al.
INTENSIVE CARE MEDICINE (2020)
Concurrent neprilysin inhibition and renin-angiotensin system modulations prevented diabetic nephropathy
Vajir Malek et al.
LIFE SCIENCES (2019)
Efficacy of lanthionine-stabilized angiotensin-(1-7) in type I and type II diabetes mouse models
Anneke Kuipers et al.
PEPTIDES (2019)
Blockade of myeloid differentiation 2 attenuates diabetic nephropathy by reducing activation of the renin-angiotensin system in mouse kidneys
Yi Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Urinary Renin in Patients and Mice With Diabetic Kidney Disease
Jeannette Tang et al.
HYPERTENSION (2019)
Addition of cyclic angiotensin-(1-7) to angiotensin-converting enzyme inhibitor therapy has a positive add-on effect in experimental diabetic nephropathy
Paola Cassis et al.
KIDNEY INTERNATIONAL (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies
Annabelle M. Warren et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2019)
Angiotensin-(1-7) and Vascular Function: The Clinical Context
Rhian M. Touyz et al.
HYPERTENSION (2018)
Update of pathophysiology and management of diabetic kidney disease
Yi-Chih Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
Increased urinary angiotensin converting enzyme 2 and neprilysin in patients with type 2 diabetes
Sridevi Gutta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2018)
Nrf2 Deficiency Upregulates Intrarenal Angiotensin-Converting Enzyme-2 and Angiotensin 1-7 Receptor Expression and Attenuates Hypertension and Nephropathy in Diabetic Mice
Shuiling Zhao et al.
ENDOCRINOLOGY (2018)
Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy
Jan Wysocki et al.
KIDNEY INTERNATIONAL (2017)
Quantification of systemic renin-angiotensin system peptides of hypertensive black and white African men established from the RAS-Fingerprint
J. M. van Rooyen et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2016)
A local renal renin-angiotensin system activation via renal uptake of prorenin and angiotensinogen in diabetic rats
Akihiro Tojo et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2016)
Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney
Oliver Domenig et al.
SCIENTIFIC REPORTS (2016)
Urinary Angiotensin Converting Enzyme 2 Increases in Patients With Type 2 Diabetic Mellitus
Yaoxian Liang et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2015)
Angiotensin(1-7) attenuates the progression of streptozotocin-induced diabetic renal injury better than angiotensin receptor blockade
Kai Zhang et al.
KIDNEY INTERNATIONAL (2015)
Valsartan slows the progression of diabetic nephropathy in db/db mice via a reductiorr in podocyte injury, and renal oxidative stress and inflammation
Guangyu Zhou et al.
CLINICAL SCIENCE (2014)
Angiotensin-Converting Enzyme 2-Independent Action of Presumed Angiotensin-Converting Enzyme 2 Activators Studies In Vivo, Ex Vivo, and In Vitro
Philipp K. Haber et al.
HYPERTENSION (2014)
Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE/ADAM-17: A positive feedback mechanism in the RAS
Vaibhav B. Patel et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Characterization of Angiotensin-Converting Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular Cells
Fengxia Xiao et al.
PLOS ONE (2014)
Angiotensin 1-7 mediates renoprotection against diabetic nephropathy by reducing oxidative stress, inflammation, and lipotoxicity
Jun Mori et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Insulin treatment attenuates renal ADAM17 and ACE2 shedding in diabetic Akita mice
Esam S. B. Salem et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)
Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
Manuel Haschke et al.
CLINICAL PHARMACOKINETICS (2013)
Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice
Renisha Nadarajah et al.
KIDNEY INTERNATIONAL (2012)
Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes
Liliya M. Yamaleyeva et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Angiotensin-(1-7) attenuates diabetic nephropathy in Zucker diabetic fatty rats
Jorge F. Giani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
David R. Whiting et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2011)
Telmisartan attenuates oxidative stress and renal fibrosis in streptozotocin induced diabetic mice with the alteration of angiotensin-(1-7) mas receptor expression associated with its PPAR-γγ agonist action
Arun Prasath Lakshmanan et al.
FREE RADICAL RESEARCH (2011)
Angiotensin-Converting Enzyme (ACE) 2 Overexpression Ameliorates Glomerular Injury in a Rat Model of Diabetic Nephropathy: A Comparison with ACE Inhibition
Chun Xi Liu et al.
MOLECULAR MEDICINE (2011)
Prediction of Off-Target Effects on Angiotensin-Converting Enzyme 2
Lidia V. Kulemina et al.
JOURNAL OF BIOMOLECULAR SCREENING (2011)
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Gavin Y. Oudit et al.
DIABETES (2010)
Targeting the Degradation of Angiotensin II With Recombinant Angiotensin-Converting Enzyme 2 Prevention of Angiotensin II-Dependent Hypertension
Jan Wysocki et al.
HYPERTENSION (2010)
Renal ACE2 expression and activity is unaltered during established hypertension in adult SHRSP and TGR(mREN2)27
Jelena Kamilic et al.
HYPERTENSION RESEARCH (2010)
Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice
Atsushi Shiota et al.
HYPERTENSION RESEARCH (2010)
Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
Leon D. Kluskens et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
The sweeter side of ACE2: Physiological evidence for a role in diabetes
Sharell M. Bindom et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan
Maria Jose Soler et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
Heather N. Reich et al.
KIDNEY INTERNATIONAL (2008)
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice
M. J. Soler et al.
KIDNEY INTERNATIONAL (2007)
Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats
J. Joyner et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: Implications for albuminuria in diabetes
Minghao Ye et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
ACE and ACE2 activity in diabetic mice
Jan Wysocki et al.
DIABETES (2006)
New mass spectrometric assay for angiotensin-converting enzyme 2 activity
KM Elased et al.
HYPERTENSION (2006)
Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy
T Konoshita et al.
DIABETES CARE (2006)
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules
NJ Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2005)
Renal ACE2 expression in human kidney disease
AT Lely et al.
JOURNAL OF PATHOLOGY (2004)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice - A renoprotective combination?
MH Ye et al.
HYPERTENSION (2004)
Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy
S Mezzano et al.
KIDNEY INTERNATIONAL (2003)
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
C Tikellis et al.
HYPERTENSION (2003)
Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase
C Vickers et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A human homolog of angiotensin-converting enzyme - Cloning and functional expression as a captopril-insensitive carboxypeptidase
SR Tipnis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
M Donoghue et al.
CIRCULATION RESEARCH (2000)
Share Paper
